PUBLISHER: The Business Research Company | PRODUCT CODE: 1942544
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942544
Cell processing instruments are specialized equipment designed for the precise handling of cells in both laboratory and production settings. They are developed to ensure accuracy, sterility, and consistency, supporting the preparation and manipulation of cells under standardized conditions. Equipped with advanced features, these instruments provide high performance, reliability, and compliance with safety and regulatory requirements.
The primary types of cell processing instruments include cell counters, cell imaging systems, flow cytometers, cell separator systems, automated cell processing systems, and others. Cell counters are devices specifically used to measure the number of cells in a sample quickly and accurately. These instruments are applied in processes such as cell isolation or separation, cell imaging and counting, cell viability and proliferation studies, and more. They serve a wide range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs) and contract manufacturing organizations (CMOs), academic and research institutes, and others.
Tariffs have influenced the cell processing instruments market by increasing the cost of imported high-precision instruments such as flow cytometers, cell separators, and automated processing systems. Segments like advanced imaging systems and integrated platforms are most affected, particularly in Asia-Pacific regions including China and India, which are key manufacturing hubs. This has resulted in higher production costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing, innovation in instrument design, and investment in domestic production capacities.
The cell processing instruments market research report is one of a series of new reports from The Business Research Company that provides cell processing instruments market statistics, including cell processing instruments industry global market size, regional shares, competitors with a cell processing instruments market share, detailed cell processing instruments market segments, market trends and opportunities, and any further data you may need to thrive in the cell processing instruments industry. This cell processing instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell processing instruments market size has grown strongly in recent years. It will grow from $6.95 billion in 2025 to $7.51 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to limited automation in cell processing, reliance on manual cell counting and separation, growing academic and research activities, increasing demand for accurate cell analysis, emergence of flow cytometry technologies.
The cell processing instruments market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of integrated cell processing platforms, rising investment in cell therapy and regenerative medicine, adoption of digital and automated imaging systems, increasing contract research and manufacturing activities, advancements in live cell analysis and high-content screening. Major trends in the forecast period include rising demand for automated cell processing systems, increasing adoption of flow cytometry and high-content imaging, growth in cell therapy and regenerative medicine applications, emphasis on standardization and regulatory compliance, integration of multi-functional cell analysis platforms.
The rising investment in biopharmaceutical research is expected to drive the growth of the cell processing instruments market in the coming years. Biopharmaceutical research involves the scientific investigation and development of therapeutic products derived from biological sources or engineered to replicate biological molecules for the diagnosis, prevention, or treatment of diseases. The increase in investment in biopharmaceutical research is driven by the growing demand for innovative therapies to address the rising burden of chronic diseases and unmet medical needs, leading to expanded research and development activities focused on targeted and effective treatments. Cell processing instruments facilitate biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, thereby accelerating the development and manufacturing of advanced cell-based therapies. For example, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector recorded significant growth in 2024, raising £3.5 billion (approximately $4.4 billion) in investment, representing a 94% increase compared to the previous year. Therefore, the increasing investment in biopharmaceutical research is fueling the growth of the cell processing instruments market.
Companies in the cell processing instruments market are focusing on technological innovations such as multi-channel asynchronous processing to improve workflow efficiency and flexibility in cell therapy development. Multi-channel asynchronous processing allows systems to run multiple independent workflows simultaneously on separate channels, enabling parallel operations without waiting for one another to finish. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, introduced two new instruments, Python Junior and Matrix NEO, to enhance and standardize single-cell analysis workflows. Python Junior facilitates the dissociation of solid tissues into high-quality single-cell suspensions using dual independent channels and a combination of mechanical and enzymatic processing. Matrix NEO enables high-throughput, fully automated single-cell library preparation with chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, supporting a wide range of research and clinical applications.
In February 2023, Cytek Biosciences, a US-based life sciences company, acquired the flow cytometry imaging business from DiaSorin for an undisclosed amount. This acquisition was aimed at expanding Cytek's global presence and strengthening its advanced cell analysis portfolio by integrating Luminex's Flow Cytometry and Imaging business unit, including its technologies, expertise, and established customer network. DiaSorin S.p.A. is an Italy-based company that manufactures cell processing instruments.
Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.
North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell processing instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell processing instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cell processing instruments market consists of sales of centrifuges, microfluidic cell processors, single-use tubing and connectors, sterile filling, and sealing equipment. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Processing Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cell processing instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cell processing instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell processing instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.